Published in Haematologica on December 01, 2008
HLA-matched sibling bone marrow transplantation for β-thalassemia major. Blood (2010) 1.20
Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel. Haematologica (2014) 1.00
Hematopietic stem cell transplantation in thalassemia and related disorders. Mediterr J Hematol Infect Dis (2009) 0.82
Health-related quality of life (HRQL) in children with sickle cell disease and thalassemia following hematopoietic stem cell transplant (HSCT). Pediatr Blood Cancer (2011) 0.80
Second bone marrow transplantation for patients with thalassemia: risks and benefits. Haematologica (2009) 0.78
Hematopoietic stem cell transplantation activity and trends at a pediatric transplantation center in Turkey during 1998-2008. Turk J Haematol (2012) 0.75
Cure for thalassemia major: from allogeneic hematopoietic stem cell transplantation to gene therapy. Haematologica (2016) 0.75
Cardiovascular events and intensity of treatment in polycythemia vera. N Engl J Med (2012) 5.87
Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00. J Clin Oncol (2010) 1.77
Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling. Blood (2013) 1.68
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study. Haematologica (2007) 1.54
New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years. Blood (2004) 1.51
Reproducibility of liver iron concentration measured on a biopsy sample: a validation study in vivo. Am J Hematol (2014) 1.44
Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation. Blood (2002) 1.40
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia. Blood (2010) 1.34
Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study. Haematologica (2009) 1.28
Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. Clin Cancer Res (2009) 1.21
Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias. Haematologica (2008) 1.19
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R. Blood (2014) 1.19
Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel. Blood (2010) 1.17
Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study. Haematologica (2009) 1.15
High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program. Haematologica (2013) 1.12
Hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria: long-term results of a retrospective study on behalf of the Gruppo Italiano Trapianto Midollo Osseo (GITMO). Haematologica (2009) 1.10
Correction of anemia in a transfusion-dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade, ICL670). Eur J Haematol (2007) 1.07
Reversibility of cirrhosis in patients cured of thalassemia by bone marrow transplantation. Ann Intern Med (2002) 1.06
CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual disease. Haematologica (2011) 1.05
Hepatitis B virus-related liver disease in isolated anti-hepatitis B-core positive lymphoma patients receiving chemo- or chemo-immune therapy. Haematologica (2008) 1.04
New strategies in the treatment of the thalassemias. Annu Rev Med (2005) 1.03
Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Clin Infect Dis (2009) 1.02
Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel. Haematologica (2014) 1.00
Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia. Haematologica (2007) 0.99
Risk of malignant lymphoma following viral hepatitis infection. Int J Hematol (2008) 0.94
Anemia in beta-thalassemia patients targets hepatic hepcidin transcript levels independently of iron metabolism genes controlling hepcidin expression. Haematologica (2008) 0.93
HIF-1α of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target. Clin Cancer Res (2013) 0.87
Glucose-6-phosphate dehydrogenase polymorphism and lymphoma risk. Tumori (2007) 0.85
High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trial. Haematologica (2005) 0.85
Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes. Br J Haematol (2014) 0.84
Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia. Hematol Oncol (2008) 0.84
Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients. J Pathol (2012) 0.84
Hematopietic stem cell transplantation in thalassemia and related disorders. Mediterr J Hematol Infect Dis (2009) 0.82
Patient- versus physician-reporting of symptoms and health status in chronic myeloid leukemia. Haematologica (2013) 0.82
The role of oxidant injury in the pathophysiology of human thalassemias. Redox Rep (2003) 0.82
Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome. Am J Hematol (2013) 0.81
Primary non-Hodgkin's lymphoma of the breast: a report of 11 cases. Haematologica (2004) 0.81
Unexpected CNS localization in M2 acute myeloid leukemia: a link with past heroin addiction? Am J Hematol (2008) 0.80
Clinical management of gastrointestinal disturbances in patients with myelodysplastic syndromes receiving iron chelation treatment with deferasirox. Leuk Res (2011) 0.80
Treatment of hepatitis C in patients with thalassemia. Haematologica (2008) 0.80
Household contact with pets and birds and risk of lymphoma. Cancer Causes Control (2010) 0.80
The evolving clinical scenario of myelodysplastic syndrome: the need for a complete and up to date upfront diagnostic assessment. Eur J Intern Med (2010) 0.78
Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients. Am J Hematol (2012) 0.78
Treosulfan/fludarabine as an allogeneic hematopoietic stem cell transplant conditioning regimen for high-risk patients. Am J Hematol (2008) 0.77
Correlation between eight-gene expression profiling and response to therapy of newly diagnosed multiple myeloma patients treated with thalidomide-dexamethasone incorporated into double autologous transplantation. Ann Hematol (2013) 0.76
Another Step Forward in Iron Chelation Therapy. Acta Haematol (2015) 0.76
Reduced Left Ventricular Contractile Reserve Identified by Low Dose Dobutamine Echocardiography as an Early Marker of Cardiac Involvement in Asymptomatic Patients with Thalassemia Major. Echocardiography (1996) 0.76
High prevalence of non-HFE gene-associated haemochromatosis in patients from southern Italy. Clin Chem Lab Med (2004) 0.75
Patterns of iron distribution in liver cells in beta-thalassemia studied by X-ray microanalysis. Haematologica (2002) 0.75
Sudden cardiac failure in a beta-thalassemia major patient receiving chemotherapy for acute promyelocytic leukemia. Leuk Lymphoma (2007) 0.75
Marginal zone B-cell lymphoma arising in donor cells in a Hepatitis-C virus infected patient over 20 years after allogeneic bone marrow transplantation. Leuk Lymphoma (2008) 0.75
Iron overload, cardiac iron loading and function in myelodysplastic syndrome. Leuk Res (2009) 0.75
Quality of life in elderly patients with essential thrombocythaemia. An Italian multicentre study. Ann Hematol (2011) 0.75
Do matrix metalloproteinase-1 and glucose-6-phosphate dehydrogenase gene polymorphisms interact in promoting lymphoma development? Leuk Lymphoma (2013) 0.75
Cardiogenic Shock during First Infusion of Anthracycline Chemotherapy in a Patient with Hodgkin Lymphoma: An Unusual Event. Cardiology (2017) 0.75